文献速递慢性静脉疾病

热消融后大/小隐静脉再通行二次消融的疗效

Secondary Ablation of Recanalized Saphenous Vein after Endovenous Thermal Ablation.
PubMed 文献 · Ann Vasc Surg · 2020-04-25

该回顾性队列研究纳入2015年6月至2018年5月间因热消融后大隐静脉或小隐静脉再通而接受二次消融的症状性患者10例(15条肢体),中位随访13个月,1年闭塞率93.3%,无并发症,静脉临床严重程度评分从术前9降至4。

要点

  • 热消融后再通行二次消融1年闭塞率93.3%。
  • 二次消融后无并发症,临床症状改善。
  • 二次消融可作为再通症状性患者的治疗选择。

核心结论

  • 二次消融治疗热消融后再通的大隐静脉或小隐静脉,1年闭塞率93.3%,临床症状改善且无并发症。

研究设计与样本

  • 回顾性队列研究,基于前瞻性收集的数据,纳入2015年6月至2018年5月间热消融后再通并接受二次消融的症状性患者10例(15条肢体)。

主要发现

  • 患者中位年龄67岁,男性占60%,距首次消融中位时间7.3年(IQR 6.5-9.6)。
  • 二次消融采用射频消融12条肢体(80%),超声引导泡沫硬化剂治疗3条(20%);治疗血管为大隐静脉14例(93.3%)。
  • 中位随访13个月,无并发症报告;术前和1年随访静脉临床严重程度评分分别为9(IQR 5-10)和4(IQR 2-8)。
  • 1年双功超声评估闭塞率93.3%,1条治疗肢体显示部分再通。

临床怎么用

  • 对于热消融后再通且存在症状的大隐静脉或小隐静脉患者,二次消融可作为有效治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To describe the occlusion rate and clinical response of a redo ablative procedure in symptomatic patients with recanalization of saphenous vein after endovascular thermal ablation. METHODS: A retrospective cohort study was performed in a prospectively collected data of symptomatic patients with recanalization of the great saphenous vein (GSV) or small saphenous vein (SSV) after endovascular thermal ablation who underwent a secondary ablation (SA) from June 2015 to May 2018. RESULTS: Ten patients (15 limbs) with recanalization of the GSV or SSV were treated with SA. The median age was 67 years and 60% were men. The median time from the first ablation was 7.3 years (interquartile range [IQR] 6.5-9.6). For SA, radiofrequency ablation was performed in 12 limbs (80%) and ultrasound-guided foam sclerotherapy in 3 cases (20%). The GSV was the treated vessel in 14 cases (93.3%). No complications were reported. Median follow-up was 13 months. Preoperative and 1-year follow-up Venous Clinical Severity Score was 9 (IQR 5-10) and 4 (IQR 2-8), respectively. Duplex ultrasound evaluation after 1 year showed an occlusion rate of 93.3% evidencing a partially recanalized vein in 1 treated limb. CONCLUSIONS: In this study, the occlusion rate was 93.3% at 1 year after SA; clinical improvement and no complications were reported. SA appears to be a valid option for the treatment of symptomatic patients with recanalized GSV or SSV.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rodriguez Santos F, Loson V, Coria A, et al. Secondary Ablation of Recanalized Saphenous Vein after Endovenous Thermal Ablation. Ann Vasc Surg. 2020. PMID: 32339689. doi:10.1016/j.avsg.2020.04.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。